Signature Resources Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.05K Hold
45
﹤0.01% 378
2026
Q1
$6.87K Hold
45
﹤0.01% 341
2025
Q4
$6.2K Hold
45
﹤0.01% 344
2025
Q3
$5.77K Hold
45
﹤0.01% 333
2025
Q2
$5.45K Hold
45
﹤0.01% 333
2025
Q1
$5.02K Hold
45
﹤0.01% 260
2024
Q4
$4.38K Hold
45
﹤0.01% 265
2024
Q3
$5.18K Hold
45
﹤0.01% 252
2024
Q2
$4.79K Hold
45
﹤0.01% 269
2024
Q1
$4.54K Hold
45
﹤0.01% 256
2023
Q4
$4.54K Buy
+45
New +$4.34K ﹤0.01% 257

Other funds holding NVS

Signature Resources Capital Management's NVS Position: Q2 2026 in Review

Signature Resources Capital Management held its Novartis (NVS) position steady in Q2 2026 at 45 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Signature Resources Capital Management first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Signature Resources Capital Management held 45 shares of Novartis worth $7.05K as of Q2 2026.
  • Signature Resources Capital Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #378 holding.
  • Signature Resources Capital Management first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.